Innogen · News · March 29, 2013

Innogen Weekly News Roundup (16/03/13 - 29/03/13)

Innogen Weekly News Roundup (16/03/13 - 29/03/13)

All the latest news from around the world on the life sciences and emerging technologies.

A weekly roundup of global news on topics, including: agriculture, the bioeconomy, food and energy security, genes and genomics, global health and development, healthcare, innovation systems, pharma, synthetic biology, science and technology.


Genetically modified potatoes are studied, criticized in Ireland (Washington Post)

Fowl play: How supply management is thwarting Canada’s agri-food industry (The Globe and Mail)

GM bananas to make Indians ‘super healthy’ (Hindustan Times)

It’s all in the genes – preventing rapeseed crop failure (Farming Life)

Synthetic vaccine could prevent future outbreaks of foot-and-mouth disease (Nature)

Critics slam Obama for “protecting” Monsanto (CBS News)


Why wait until death for organ donation, asks Canadian bioethicist (BioEdge)

Food & Energy Security

Time to Create the Energy Security Trust (White House Press Office)

Bloated biofuels (Financial Times)


Don’t fear babies made with genes from three patients (New Scientist)

Map of ‘Shortcuts’ Between All Human Genes Created (Bioscience Technology)

Global Health

The Lancet to Launch Open Access Global Health Journal (All Africa)

New vaccine-design approach targets HIV and other fast-mutating viruses (Medical Xpress)


Mayo Clinic to hold trial for BrainStorm’s ALS stem cell therapy (Reuters)

Global Health Agencies Need ‘Significant Funding’ to Combat Rise of Drug-Resistant Tuberculosis (Think Progress)

The Rare Disease Search Engine That Outperforms Google (MIT Technology Review)

Implant coating could warn doctors of healing problems (The Engineer)

EU hesitates to follow US approach on medical devices (EurActiv)

‘Most family doctors’ have given a patient a placebo drug (BBC News)

Study of genetically modified immune cells could help improve promising treatment for melanoma (News Medical)

Tiny implant sends heart attack warning to smartphone (Fox News)

Stem-cell ruling riles researchers (Nature)

Scientists unravel genetic causes of prostate, breast and ovarian cancer (The Guardian)

Cancer scientists hope genetic markers will reveal how disease develops (The Guardian)

Bumper haul of cancer genes promises better prevention (New Scientist)

Scientists criticize Italy for allowing unproven stem cell therapy (Reuters)

Innovation Systems

Three innovation myths (Financial Times)

Financial Assessment of the Global Pharmaceutical and Biotechnology Industry (International Business Times)


Biosimilars bills move on in two US states (Gabi Online)

Battler over ‘biosimilars’ (Los Angeles Times)

How fresh is Big Pharma’s Freshness Index? (Forbes)

Jeopardizing U.S. Drug Development (IP Watchdog)

Supreme Court Hears ‘Pay to Delay’ Pharmaceutical Case (NPR)

First US state biosimilars bill becomes law (PharmaTimes)

Do You Think ‘Biosimilars’ Will Reduce Healthcare Expenditures? Think again. (Forbes)

Do you own your genes, or can Big Pharma patent them? (Extreme Tech)

Companies own your genes via 40,000 patents (Science Blog)

Science & Technology

Long-term research: Slow science (Nature)

Stem cell scientists simplify pitches (San Francisco Chronicle)

Better Made Up: does all innovation begin as science fiction? (Guardian)

Synthetic Biology

Synthetic Biology Remains a Mystery (Market Watch)

Awareness & Impressions of Synthetic Biology (Wilson Center)

Quality control opens path to synthetic biology’s Ikea (New Scientist)